¹þ¹þÌåÓý

²úÆ·ÖÐÐÄ

ÁªÏµ¹þ¹þÌåÓý

+86-010-82156767

ÏúÊÛרÓãº

+86-010-62983737 

+86-15522507305 

+86-15522507319 

+86-15522507326

µØµã£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã

³¤Ð§¶àëÄÖ¬·¾Ëá²àÁ´

ÒȸßѪÌÇËØÑùëÄ-1£¨Glucagon-like Peptide-1, GLP-1£©ÊÇÓÉÈ˳¦µÀÉøÍ¸µÄÒ»ÖÖëÄÀà¼¤ËØ£¬£¬Ëü¿É´Ì¼¤Òȵºβϸ°ûÉøÍ¸ÒȵºËØ£¬£¬¼ÓÈëÌåÄÚѪÌÇÆ½ºâµ÷Àí¡£¡£¡£GLP-1ÊÜÌ弤¶¯¼ÁÒѱ»ÆÕ±éÓ¦ÓÃÓÚ2ÐÍÌÇÄò²¡ºÍ·ÊÅÖµÄÖÎÁÆ¡£¡£¡£

ʹÓÃÖ¬·¾Ëá²àÁ´ÐÞÊÎÊÖÒÕ£¬£¬¿ÉʵÏÖGLP-1ÀàËÆÎïµÄ³¤Ð§»¯£¬£¬¼«´óÌá¸ß»¼ÕßÒÀ´ÓÐÔ¡£¡£¡£Ö¬·¾ËáÄܹ»ÒÔ¿ÉÄæµÄ·½·¨ÓëѪ½¬°×ÂѰף¨human serum albumin£¬£¬HSA£©Á¬Ïµ£¬£¬±£»£»£»£»£»¤¶àëÄÃâÊÜDPP-IV ½µ½âºÍÉö¹ýÂË£¬£¬´Ó¶øÑÓÉìÒ©Îï°ëË¥ÆÚ¡£¡£¡£

ÏÖÔÚÊг¡Ö÷Á÷³¤Ð§GLP-1ÊÜÌ弤¶¯¼Á£¬£¬ÈçÀûÀ­Â³ëÄ£¨Liraglutide£©¡¢Ë¾ÃÀ¸ñ³ëÄ£¨Semaglutide£© ºÍÌæ¶û²´ëÄ£¨Tirzepatide£©,¾ù½ÓÄÉÖ¬·¾Ëá²àÁ´ÐÞÊÎÊÖÒÕ¡£¡£¡£

 

Fig 1˾ÃÀ¸ñ³ëĺÍÌæ¶û²´ëĽṹ

Fig 1 The Structure of Semaglutide and Tirzepatide

¹þ¹þÌåÓý¿Æ¼¼¿ÉÌṩʵÑéÊÒ¼°GMP¼¶±ðµÄ¸ßƱðÀ묷¾Ëá²àÁ´²úÆ·£¬£¬Æä׿ԽµÄ´¿¶ÈºÍ´ó¹æÄ£µÄÉú²úÄÜÁ¦£¬£¬È·±£Á˲úÆ·µÄÒ»ÖÂÐԺͿɿ¿ÐÔ£¬£¬µ¥Åú´Î²úÁ¿¿ÉµÖ´ï10¹«½ï£¬£¬²¢¿ÉÀ©Õ¹ÖÁ100¹«½ï£¬£¬Öª×ãÄú´ÓÔçÆÚÒ©ÎïÑз¢µ½ÉÌÒµ»¯Éú²úÈ«Á÷³ÌµÄÐèÇ󡣡£¡£

¹«Ë¾³Ð¼ÌÒÔÖÊÁÏÁ¢ÒìÒýÁìÉúÎïÒ½Ò©Á¢ÒìµÄ×ÚÖ¼£¬£¬×¢ÖØÊÖÒÕÑз¢£¬£¬ÈçÄúÐèÒªÆäËüδÁгöµÄ½á¹¹£¬£¬½Ó´ýÄúÀ´µç×Éѯ£¬£¬¹þ¹þÌåÓý¿Æ¼¼¿ÉÌṩ²àÁ´Àà²úÆ·µÄ¶¨ÖƺϳÉЧÀÍ£¬£¬ÎªÄúµÄÑз¢ÏîÄ¿ÌṩÖÜȫ֧³Ö¡£¡£¡£

ÐòºÅ

Æ·Ãû

´úºÅ

½á¹¹Ê½

´¿¶È

+

tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu

¡Ý98%

OH-Ste-Glu(AEEA-AEEA-OSu)-OH

¡Ý90%

tBuO-Ste-Glu(AEEA-AEEA-OSu)-OtBu

¡Ý95%

Fmoc-Lys(tBuO-Ste-Glu(AEEA-AEEA)-OtBu)-OH

¡Ý98%

tBuO-ICO-Glu(AEEA-AEEA-OH)-OtBu

¡Ý98%

OH-ICO-Glu(AEEA-AEEA-OSu)-OH

¡Ý90%

tBuO-ICO-Glu(AEEA-AEEA-OSu)-OtBu

¡Ý95%

Fmoc-Lys(tBuO-ICO-Glu(AEEA-AEEA)-OtBu)-OH

¡Ý98%

< 1 > ǰÍù Ò³
¡¾ÍøÕ¾µØÍ¼¡¿